Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
Brazil expands pesticide packaging reverse logistics - 2See the famous winged horse Pegasus fly in the autumn night sky
- 3What you need to know about desalination, a growing source of drinking water
- 4April's full moon decides the date of Easter — here's how it works
- 52025 among world's three hottest years on record, WMO says
- Daily Briefing: A bad flu season gets worse
- Closets for Your Room: Plan and Utility Features
- US FDA panel to weigh bid to market nicotine pouches as lower-risk than cigarettes
- As juries turn against social media for harming kids, Big Tech's invincibility starts to show cracks
- The most effective method to Go Down Abundance through Ages with Disc Rates
- One ant for $220: the new frontier of wildlife trafficking
- Pick Your Favored kind of sandwich
- The Most Important Crossroads in Olympic History
- Artemis 2 astronauts fly around the moon in record-breaking lunar loop by NASA
